SUPPLEMENTARY TABLES Supplementary
Mixed micelles comprised linoleic acid and HCO60 were filtered through a membrane filter (pore size, 0.45 μm). Lymph was collected via a thoracic duct fistula of the mice under the postprandial conditions, followed by ultracentrifugation to obtain the chylomicron fraction (CM). Toc-siRNA was incubated in vitro with MM, lymph, and CM at 37°C for 30 min. The particle size and size distribution were determined by DLS (Photal ELSZ-2). All samples in this table showed only one peak in the size distribution. The peak diameter and polydispersity index were calculated by a cumulant method. 
SUPPLEMENTARY METHODS
Particle sizing by dynamic light scattering (DLS). Particle size distribution was evaluated by DLS (PhotalELSZ-2, Otsuka Electronics Co. Ltd., Osaka, Japan). Toc-siRNA was incubated in vitro with linoleic acid-HCO60 mixed micelles at 37°C for 30 min, and formation of complexes was confirmed by DLS.
Concentration of Toc-siRNA in each organ. In rectal administration, mice were administered with Cy3-conjugated Toc-siRNA, and 4 h later various organs (liver, kidney, spleen, jejunum, lung and brain) and serum were harvested. In intravenous injection, mice were injected from tail vein with Cy3-conjugated Toc-siRNA, and 1 h later liver and serum were harvested. The signal intensity of Cy3 in the samples was measured by i-control (Tecan, Männedorf, Switzerland), then the concentration of Toc-siRNA was calculated.
